Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Ayton

Showing results (71-80 of 141) with videos related to

Pageof 15
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 25, 2021
Regional brain iron associated with deterioration in Alzheimer's disease: A large cohort study and theoretical significanceScott Ayton, Stuart Portbury, Pawel Kalinowski, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 9, 2021
Characterization of Selenium Compounds for Anti-ferroptotic Activity in Neuronal Cells and After Cerebral Ischemia-Reperfusion InjuryQing-Zhang Tuo, Shashank Masaldan, Adam Southon, et al.
The Journal of Biological Chemistry|January 17, 2021
Fibrillar α-synuclein toxicity depends on functional lysosomesStephanie J Guiney, Paul A Adlard, Peng Lei, et al.
The Neuroradiology Journal|December 4, 2024
Quantitative susceptibility mapping of the fear circuit: Associations with silent symptoms in relapsing-remitting multiple sclerosisIbrahim Khormi, Amir Fazlollahi, Oun Al-Iedani, et al.
Plos One|January 30, 2014
Increased Ndfip1 in the substantia nigra of Parkinsonian brains is associated with elevated iron levelsJason Howitt, Amanda M Gysbers, Scott Ayton, et al.
Journal of Molecular Neuroscience : MN|May 14, 2010
α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatmentSonia George, Su San Mok, Milawaty Nurjono, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersPratishtha Chatterjee, Pawel Kalinowski, Anne M Roberts, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisSonal Agrawal, Sue E Leurgans, Scott Ayton, et al.
Annals of Neurology|February 21, 2013
Ceruloplasmin dysfunction and therapeutic potential for Parkinson diseaseScott Ayton, Peng Lei, James A Duce, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 15, 2019
Brain Zinc Deficiency Exacerbates Cognitive Decline in the R6/1 Model of Huntington's DiseaseScott Ayton, Peng Lei, Ambili T Appukuttan, et al.
Pageof 15

Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 25, 2021
Regional brain iron associated with deterioration in Alzheimer's disease: A large cohort study and theoretical significanceScott Ayton, Stuart Portbury, Pawel Kalinowski, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 9, 2021
Characterization of Selenium Compounds for Anti-ferroptotic Activity in Neuronal Cells and After Cerebral Ischemia-Reperfusion InjuryQing-Zhang Tuo, Shashank Masaldan, Adam Southon, et al.
The Journal of Biological Chemistry|January 17, 2021
Fibrillar α-synuclein toxicity depends on functional lysosomesStephanie J Guiney, Paul A Adlard, Peng Lei, et al.
The Neuroradiology Journal|December 4, 2024
Quantitative susceptibility mapping of the fear circuit: Associations with silent symptoms in relapsing-remitting multiple sclerosisIbrahim Khormi, Amir Fazlollahi, Oun Al-Iedani, et al.
Plos One|January 30, 2014
Increased Ndfip1 in the substantia nigra of Parkinsonian brains is associated with elevated iron levelsJason Howitt, Amanda M Gysbers, Scott Ayton, et al.
Journal of Molecular Neuroscience : MN|May 14, 2010
α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatmentSonia George, Su San Mok, Milawaty Nurjono, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersPratishtha Chatterjee, Pawel Kalinowski, Anne M Roberts, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisSonal Agrawal, Sue E Leurgans, Scott Ayton, et al.
Annals of Neurology|February 21, 2013
Ceruloplasmin dysfunction and therapeutic potential for Parkinson diseaseScott Ayton, Peng Lei, James A Duce, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 15, 2019
Brain Zinc Deficiency Exacerbates Cognitive Decline in the R6/1 Model of Huntington's DiseaseScott Ayton, Peng Lei, Ambili T Appukuttan, et al.
Pageof 15